​

Cyclerion Therapeutics (CYCN) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Cyclerion Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$194.00K

Cyclerion Therapeutics Revenue by Period

Cyclerion Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$297.00K-91.05%
2021-12-31$3.32M44.60%
2020-12-31$2.30M-49.06%
2019-12-31$4.51M100.00%
2018-12-31-100.00%
2017-12-31--

Cyclerion Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Cyclerion Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$194.00K100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$1.63M100.00%
2022-09-30--100.00%
2022-06-30$72.00K-68.00%
2022-03-31$225.00K23.63%
2021-12-31$182.00K136.36%
2021-09-30$77.00K-97.43%
2021-06-30$3.00M4738.71%
2021-03-31$62.00K-53.38%
2020-12-31$133.00K-66.75%
2020-09-30$400.00K-46.60%
2020-06-30$749.00K-26.13%
2020-03-31$1.01M-31.53%
2019-12-31$1.48M5.94%
2019-09-30$1.40M-14.13%
2019-06-30$1.63M100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Cyclerion Therapeutics generated $194.00K in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Cyclerion Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIPOLipella Pharmaceuticals$449.62M$80.38M
FENCFennec Pharmaceuticals$21.64M$6.97M
KZRKezar Life Sciences$7.00M-
KRONKronos Bio$6.29M$2.37M
SNTISenti Biosciences$2.56M-
ADXNAddex Therapeutics$1.61M$235.00K
SONNSonnet BioTherapeutics$147.81K-
FBRXForte Biosciences--
XFORX4 Pharmaceuticals-$560.00K
ERASErasca--
ACHLAchilles Therapeutics--
LRMRLarimar Therapeutics--
MNPRMonopar Therapeutics--
ZVSAZyVersa Therapeutics--
CYCNCyclerion Therapeutics-$194.00K
CDIOCardio Diagnostics-$6.58K

CYCN Revenue FAQ

What is Cyclerion Therapeutics’s yearly revenue?

Cyclerion Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $297K, representing a decrease of -91.05% compared to 2021. CYCN's yearly revenue for 2021 was $3.32M, representing an increase of 44.60% compared to 2020.

What is Cyclerion Therapeutics’s quarterly revenue?

Cyclerion Therapeutics's quarterly revenue for Q3 2024 was $194K, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). CYCN's quarterly revenue for Q1 2024 was $0, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Cyclerion Therapeutics’s revenue growth rate?

Cyclerion Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.